Anti-inflammatory composition
AssigneeOsteoneurogen Inc.
InventorsByung Soo Youn, Han Soo Kim, Ik Hwan Kim, Ho Sup Yoon, Moon Kee Maeng, Baik Lin Seong, Min Ju Ham, Hyeong Deok Choi
Life of this patent
Estimating the term…
Loading patent…
AssigneeOsteoneurogen Inc.
InventorsByung Soo Youn, Han Soo Kim, Ik Hwan Kim, Ho Sup Yoon, Moon Kee Maeng, Baik Lin Seong, Min Ju Ham, Hyeong Deok Choi
Estimating the term…
The present invention relates to an anti-inflammatory composition, and more particularly to an anti-inflammatory composition containing, as an active ingredient, a compound represented by Formula 1 or a salt thereof, wherein the anti-inflammatory composition may inhibit inflammatory response even at an early stage by inhibiting the interaction between CD14 and LPS and blocking the expression of CD14 and the expression of TNFα and IL-1β, which are the key factors in inflammatory response, and may also regulate the expression of important factors, such as CCL2 (MCP-1), CCL7 (MCP-3), CXCL2, CHOP and NOX1, which are involved in inflammatory response.
A method of treating an inflammatory disease in a subject in need thereof, comprising:
Dependencies are inferred from the claim text.